Back
Guidewire Software Vs. Denali Therapeutics Industry Stock Comparison
Buy
82
GWRE
Guidewire Software
Last Price:
174.41
Seasonality Move:
-0.55%
Buy
56
DNLI
Denali Therapeutics
Last Price:
31.75
Seasonality Move:
17.79%
Buy
82
Guidewire Software (GWRE)
is a Buy
Is Guidewire Software a Buy, Sell or Hold?
- The current Guidewire Software [GWRE] share price is $172.43. The Score for GWRE is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- GWRE is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
56
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy, Sell or Hold?
- The current Denali Therapeutics [DNLI] share price is $30.76. The Score for DNLI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- DNLI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GWRE Stock Price Chart
What is Guidewire Software's stock price today?
-
The Guidewire Software share price today is $172.43
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GWRE is experiencing slight buying pressure.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $30.76
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing selling pressure, which indicates risk of future bearish movement.
GWRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.41 | Buy |
| Relative Strength Index (14 RSI): | 77.45 | Buy |
| Chaikin Money Flow: | 426065 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (144.15 - 166.11) | Buy |
| Bollinger Bands (100): | (121.91 - 153.11) | Buy |
DNLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.79 | Buy |
| Relative Strength Index (14 RSI): | 78.12 | Buy |
| Chaikin Money Flow: | -939708 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.39 - 28.19) | Buy |
| Bollinger Bands (100): | (19.07 - 25.27) | Buy |
GWRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 170.43 | Buy |
| 20-day SMA: | 157.07 | Buy |
| 50-day SMA: | 149.45 | Buy |
| 200-day SMA: | 124.59 | Buy |
| 8-day EMA: | 168.59 | Buy |
| 20-day EMA: | 160.5 | Buy |
| 50-day EMA: | 150.7 | Buy |
| 200-day EMA: | 127.02 | Buy |
DNLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.69 | Buy |
| 20-day SMA: | 26.4 | Buy |
| 50-day SMA: | 24.37 | Buy |
| 200-day SMA: | 20.59 | Buy |
| 8-day EMA: | 29.03 | Buy |
| 20-day EMA: | 26.97 | Buy |
| 50-day EMA: | 24.8 | Buy |
| 200-day EMA: | 22.21 | Buy |
Guidewire Software Earnings Growth & GWRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.12 per share, an increase this year of $1.29 per share, and an increase next year of $0.66 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.07 per share.
Guidewire Software Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Denali Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||